INDUSTRY WATCH
About Nintx
Nintx develops next-generation medicines by taking advantage of biodiversity , mainly from Brazil . One of its key innovations is a broader approach to addressing complex or multifactorial diseases , caused by genetic and environmental factors , as well as their interactions across the human gut microbiome . Multifactorial diseases include metabolic , immunological , oncological and brain disorders . Nintx develops therapies that directly and indirectly target biological pathways through the modulation of the gut microbiome , both of which are closely related to the onset or worsening of multifactorial diseases .
“ The new C-level executive structure , in which Saverio becomes CEO , I take on the role of Chief Development Officer ( CDO ) and Cristiano remains Chief Scientific Officer ( CSO ), has been part of our strategic plan for this new phase of the startup ,” said Freitas .
“ Nintx is a rare case in Brazil , as most companies in the country focus on established technologies , which translates into a lack of global competitiveness . We are on the way to creating a biotechnology company focused on truly innovative therapies , a pioneering approach in the Brazilian pharmaceutical industry ,” said Saverio . p
62 INTELLIGENTCIO LATAM www . intelligentcio . com